Efficacy and Safety of Brodalumab in Patients with Moderate-to-Severe Plaque Psoriasis and Skin of Color: Results from the Pooled AMAGINE-2/-3 Randomized Trials

Amy J. McMichael,Seemal R. Desai,Aamir Qureshi,Shipra Rastogi,Andrew F. Alexis

Efficacy and Safety of Brodalumab in Patients with Moderate-to-Severe Plaque Psoriasis and Skin of Color: Results from the Pooled AMAGINE-2/-3 Randomized Trials

2019

Amy J. McMichael
Seemal R. Desai
Aamir Qureshi
Shipra Rastogi
Andrew F. Alexis

Background Data on treatment outcomes in patients with psoriasis who have skin of color are limited. Brodalumab has shown efficacy in patients with moderate-to-severe plaque psoriasis.

Keywords:

Dermatology
Psoriasis
Randomized controlled trial
Brodalumab
Medicine
Ustekinumab
Dermatology Life Quality Index
Psoriasis Area and Severity Index
Quality of life
Placebo

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations